Below are the most recent publications written about "Peptides, Cyclic" by people in Profiles.
-
Dahal A, Parajuli P, Singh SS, Shrestha L, Sonju JJ, Shrestha P, Chatzistamou I, Jois S. Targeting protein-protein interaction for immunomodulation: A sunflower trypsin inhibitor analog peptidomimetic suppresses RA progression in CIA model. J Pharmacol Sci. 2022 Jul; 149(3):124-138.
-
Liao L, Cen B, Li G, Wei Y, Wang Z, Huang W, He S, Yuan Y, Ji A. A bivalent cyclic RGD-siRNA conjugate enhances the antitumor effect of apatinib via co-inhibiting VEGFR2 in non-small cell lung cancer xenografts. Drug Deliv. 2021 Dec; 28(1):1432-1442.
-
Perez Ortiz G, Sidda JD, de Los Santos ELC, Hubert CB, Barry SM. In vitro elucidation of the crucial but complex oxidative tailoring steps in rufomycin biosynthesis enables one pot conversion of rufomycin B to rufomycin C. Chem Commun (Camb). 2021 Nov 09; 57(89):11795-11798.
-
Connors NJ, Hoffman RS, Gosselin S. Just the Facts: Management of cyclopeptide mushroom ingestion. CJEM. 2020 09; 22(5):644-647.
-
Pierce MR, Robinson RM, Ibarra-Rivera TR, Pirrung MC, Dolloff NG, Bachmann AS. Syrbactin proteasome inhibitor TIR-199 overcomes bortezomib chemoresistance and inhibits multiple myeloma tumor growth in vivo. Leuk Res. 2020 01; 88:106271.
-
Madaio MP, Czikora I, Kvirkvelia N, McMenamin M, Yue Q, Liu T, Toque HA, Sridhar S, Covington K, Alaisami R, O'Connor PM, Caldwell RW, Chen JK, Clauss M, Brands MW, Eaton DC, Romero MJ, Lucas R. The TNF-derived TIP peptide activates the epithelial sodium channel and ameliorates experimental nephrotoxic serum nephritis. Kidney Int. 2019 06; 95(6):1359-1372.
-
Liao W, Qin Y, Liao L, Cen B, Wu Z, Wei Y, Wang Z, Li G, Ji A. Protective effect of Gelofusine against cRGD-siRNA-induced nephrotoxicity in mice. Ren Fail. 2018 Nov; 40(1):187-195.
-
Kumarasinghe IR, Woster PM. Cyclic peptide inhibitors of lysine-specific demethylase 1 with improved potency identified by alanine scanning mutagenesis. Eur J Med Chem. 2018 Mar 25; 148:210-220.
-
He S, Cen B, Liao L, Wang Z, Qin Y, Wu Z, Liao W, Zhang Z, Ji A. A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo. Drug Deliv. 2017 Nov; 24(1):471-481.
-
Saraswathy M, Knight GT, Pilla S, Ashton RS, Gong S. Multifunctional drug nanocarriers formed by cRGD-conjugated ßCD-PAMAM-PEG for targeted cancer therapy. Colloids Surf B Biointerfaces. 2015 Feb 01; 126:590-597.